↓ Skip to main content

Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer

Overview of attention for article published in BMC Cancer, September 2011
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer
Published in
BMC Cancer, September 2011
DOI 10.1186/1471-2407-11-397
Pubmed ID
Authors

Wei-hua Zhou, Fang Tang, Jie Xu, Xing Wu, Zhi-ying Feng, Hai-gang Li, Dong-jun Lin, Chun-kui Shao, Quentin Liu

Abstract

14-3-3ơ is an intracellular, phosphoserine binding protein and proposed to be involved in tumorigenesis. However, the expression dynamics of 14-3-3ơ and its clinicopathological/prognostic significance in human tumors are still controversial.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 7%
Brazil 1 7%
Unknown 13 87%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 40%
Student > Ph. D. Student 4 27%
Student > Master 3 20%
Professor 1 7%
Unknown 1 7%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 40%
Biochemistry, Genetics and Molecular Biology 3 20%
Medicine and Dentistry 2 13%
Arts and Humanities 1 7%
Unknown 3 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2011.
All research outputs
#2,946,614
of 3,684,317 outputs
Outputs from BMC Cancer
#1,386
of 1,820 outputs
Outputs of similar age
#41,903
of 62,048 outputs
Outputs of similar age from BMC Cancer
#61
of 94 outputs
Altmetric has tracked 3,684,317 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,820 research outputs from this source. They receive a mean Attention Score of 2.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 62,048 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.